4.7 Article

Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects

Journal

ALZHEIMERS & DEMENTIA
Volume 10, Issue 5, Pages S344-S353

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jalz.2013.09.011

Keywords

Alzheimer's disease; Mild cognitive impairment; Preclinical; Predementia; AV45-PET; Amyloid; MRI; Voxel-based; Cytoarchitectonic; Cholinergic basal forebrain; Substantia innominata; Nucleus basalis Meynert

Funding

  1. Interdisciplinary Faculty, Department Individual and Societal Ageing, University of Rostock
  2. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  3. National Institute on Aging (NIA), National Institute of Biomedical Imaging and Bioengineering (NIBIB
  4. National Institute on Aging
  5. National Institute of Biomedical Imaging and Bioengineering
  6. NIH [P30 AG010129, K01 AG030514]

Ask authors/readers for more resources

Background: Both neurodegeneration of the cholinergic basal forebrain (BF) and deposition of beta-amyloid are early events in the course of Alzheimer's disease (AD). Associations between increased amyloid pathology and cholinergic atrophy have been described in autopsy studies. Methods: We used structural MRI and AV45-PET amyloid imaging data of 225 cognitively normal or mildly impaired elderly subjects from the Alzheimer's Disease Neuroimaging Initiative to assess in vivo associations between BF atrophy and cortical amyloid deposition. Associations were examined using region-of-interest (ROI) and voxel-based approaches with reference to cytoarchitectonic mappings of the cholinergic BF nuclei. Results: ROI- and voxel-based approaches yielded complementary evidence for an association between BF volume and cortical amyloid deposition in presymptomatic and predementia stages of AD, irrespective of age, gender, and APOE genotype. Conclusions: The observed correlations between BF atrophy and cortical amyloid load likely reflect associations between cholinergic degeneration and amyloid pathology as reported in neuropathologic examination studies. (C) 2014 The Alzheimer's Association. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available